Literature DB >> 19955493

Translational medicine: the antihypertensive effect of renal denervation.

Gerald F DiBona1, Murray Esler.   

Abstract

Translational medicine is concerned with the translation of research discoveries into clinical applications for the prevention, diagnosis, and treatment of human diseases. Here we briefly review the research concerning the role of the renal sympathetic nerves (efferent and afferent) in the control of renal function, with particular reference to hypertension. The accumulated evidence is compelling for a primary role of the renal innervation in the pathogenesis of hypertension. These research discoveries led to the development of a catheter-based procedure for renal denervation in human subjects. A proof-of-principle study in patients with hypertension resistant to conventional therapy has demonstrated that the procedure is safe and produces renal denervation with sustained lowering of arterial pressure.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955493     DOI: 10.1152/ajpregu.00647.2009

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  111 in total

1.  Hypertension: Renal denervation in chronic kidney disease.

Authors:  Peter J Blankestijn; Jaap A Joles
Journal:  Nat Rev Nephrol       Date:  2012-07-03       Impact factor: 28.314

Review 2.  Novel therapeutic targets for hypertension.

Authors:  Ludovit Paulis; Thomas Unger
Journal:  Nat Rev Cardiol       Date:  2010-06-22       Impact factor: 32.419

Review 3.  Premise, promise, and potential limitations of invasive devices to treat hypertension.

Authors:  Elizabeth A Martin; Ronald G Victor
Journal:  Curr Cardiol Rep       Date:  2011-02       Impact factor: 2.931

Review 4.  The rise, fall, and possible resurrection of renal denervation.

Authors:  Rajiv Gulati; Claire E Raphael; Manuela Negoita; Stuart J Pocock; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2016-02-04       Impact factor: 32.419

5.  Activation of the sympathetic nervous system, is it key to the developmental origins of enhanced cardiovascular risk?

Authors:  Barbara T Alexander; Suttira Intapad
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-05

Review 6.  The sympathetic nervous system and heart failure.

Authors:  David Y Zhang; Allen S Anderson
Journal:  Cardiol Clin       Date:  2014-02       Impact factor: 2.213

7.  Reversal of genetic salt-sensitive hypertension by targeted sympathetic ablation.

Authors:  Jason D Foss; Gregory D Fink; John W Osborn
Journal:  Hypertension       Date:  2013-02-04       Impact factor: 10.190

Review 8.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

9.  Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.

Authors:  Christopher T Banek; Mark M Knuepfer; Jason D Foss; Jessica K Fiege; Ninitha Asirvatham-Jeyaraj; Dusty Van Helden; Yoji Shimizu; John W Osborn
Journal:  Hypertension       Date:  2016-10-03       Impact factor: 10.190

10.  A linear relationship between the ex-vivo sodium mediated expression of two sodium regulatory pathways as a surrogate marker of salt sensitivity of blood pressure in exfoliated human renal proximal tubule cells: the virtual renal biopsy.

Authors:  John J Gildea; Dylan T Lahiff; Robert E Van Sciver; Ryan S Weiss; Neema Shah; Helen E McGrath; Cynthia D Schoeffel; Pedro A Jose; Robert M Carey; Robin A Felder
Journal:  Clin Chim Acta       Date:  2013-02-27       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.